RxDoctor Payments Data

Amy Williams, OD

Optometrist · Defiance, OHNPI 1811979289

Payments from drug & device makers

$412in general payments, 2019–2025

Across 22 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$84
  • Bausch & Lomb Americas Inc.$63
  • Biotissue Holdings Inc.$50
  • Dompe US, Inc.$45
  • Johnson & Johnson Vision Care, Inc.$45
  • Alcon$42
  • plus $84 from 4 others

What the payments were for

  • Food & beverage$412100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$412 in reported general payments places this provider in the 35th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio

Medicare billing

Part B allowed, 2024
$140,725
Medicare patients
782
Services billed
1,810

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost48$27,100
RestasisCyclosporine25$19,353
Cyclosporine19$15,164
Brimonidine Tartrate205$10,103
Latanoprost612$7,039
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol15$6,898
Timolol Maleate144$4,796
Bimatoprost26$4,130
Travoprost20$3,606
TobradexTobramycin/Dexamethasone13$3,413
Brinzolamide11$1,922
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat100$1,480
Dorzolamide Hcl72$1,411
Tobramycin-DexamethasoneTobramycin/Dexamethasone19$896
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha68$822

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Restasis$41$46,45473 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,995 optometrist providers in Ohio.

Other optometrist in Defiance

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →